Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

DIRECT DIGITAL HOLDINGS, INC. (DRCT)

  • Business News
  • June 04, 2026, 20:05 UTC
  • 2
  • 1 comments

Ohad Harlev Appointed to the Board of Directors of Direct Digital Holdings

Market reaction Comment Full text

AZITRA, INC. (AZTR)

  • Business News
  • June 04, 2026, 20:05 UTC
  • 6
  • 1 comments

Azitra Announces Adjournment of 2026 Annual Meeting and Information for Reconvened Meeting

Market reaction Comment Full text

SERVICETITAN, INC. (TTAN)

  • Business News
  • June 04, 2026, 20:05 UTC
  • 5
  • 1 comments

ServiceTitan Announces Fiscal First Quarter Financial Results

Market reaction Comment Full text

CONCRETE PUMPING HOLDINGS, INC. (BBCP)

  • Business News
  • June 04, 2026, 20:05 UTC
  • 3
  • 1 comments

Concrete Pumping Holdings Reports Strong Second Quarter Fiscal Year 2026 Results

Market reaction Comment Full text

MADRIGAL PHARMACEUTICALS, INC. (MDGL)

  • Business News
  • June 04, 2026, 20:05 UTC
  • 2
  • 1 comments

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

Market reaction Comment Full text

IMMUNOME INC. (IMNM)

  • Business News
  • June 04, 2026, 20:02 UTC
  • 5
  • 1 comments

Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Market reaction Comment Full text

NYXOAH SA (NYXH)

  • Business News
  • June 04, 2026, 20:02 UTC
  • 4
  • 1 comments

Nyxoah Annonce une Proposition dOffre dActions Ordinaires

Market reaction Comment Full text

NYXOAH SA (NYXH)

  • Business News
  • June 04, 2026, 20:02 UTC
  • 4
  • 1 comments

Nyxoah Announces Proposed Offering of Ordinary Shares

Market reaction Comment Full text

ESPEY MFG & ELECTRONICS CORP (ESP)

  • Business News
  • June 04, 2026, 20:01 UTC
  • 6
  • 1 comments

Espey Declares Regular Quarterly Dividend of $0.25 Per Share

Market reaction Comment Full text

NYXOAH SA (NYXH)

  • Business News
  • June 04, 2026, 20:01 UTC
  • 5
  • 1 comments

Nyxoah Entre dans une Nouvelle Phase de Création de Valeur à Long Terme

Market reaction Comment Full text
  • Previous
  • 2451
  • 2452
  • 2453
  • 2454
  • 2455
  • Next

Search

News categories

  • Technical Exchange News(13953)
  • Event(6229)
  • SEC News(353575)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(214001)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin